NOTE: This activity is available only as part of a paid subscription series; it is not available for purchase as a single, stand-alone activity.
The goal of this program is to improve the management of nasal polyps and atopic diseases using monoclonal antibodies. After hearing and assimilating this program, the clinician will be better able to:
1. Administer dupilumab to patients with corticosteroid-dependent asthma.
2. Explain the importance of fractional exhaled nitric oxide in the evaluation of efficacy of dupilumab.
3. Optimize use of dupilumab in asthmatic patients with atopic dermatitis.
- Provider:Lippincott Continuing Medical Education Institute, Inc.
- Activity Link: https:/www.audio-digest.org/Specialties/Otolaryngology
- Start Date: 2023-03-16 05:00:00
- End Date: 2023-03-16 05:00:00
- Credit Details: AMA PRA Category 1 Credit™️: 1.0 hours
- MOC Credit Details: ABOHNS - 1.0 Point; Credit Type(s): Self-Assessment (ABOHNS)
- Commercial Support: No
- Activity Type: Enduring Material
- CME Finder Type: Online Learning
- Fee to Participate: Yes
- Measured Outcome: Learner Competence, Learner Knowledge, Learner Performance
- Provider Ship: Directly Provided
- Registration: Open to all
- Specialty: Rhinology
Subscribe
Login
0 Comments
Oldest